Therakos Development Limited, a global pioneer in immunomodulatory therapy delivered at the bedside through extracorporeal ...
The IMPACT31 trial will enrol 90 high-risk liver cancer patients across the US and Asia-Pacific to evaluate GNOS-PV02 ...
New Phase II/III study will evaluate ivonescimab plus chemotherapy against existing immunotherapy-based treatments, building ...
New CAS Connections integration combines over 150 years of curated scientific knowledge with CAS Newton’s agentic AI ...
Medical device makers went digital to stay audit-ready. Yet their device history records are still being stitched together by ...
ESTEVE CDMO, Esteve Healthcare contract development and manufacturing organization, is strengthening its presence in Asia ...
NeuroXT Inc., a medical device manufacturer, announced that NEXT-Cue, its AI-based Software as a Medical Device (SaMD) ...
Insilico reached the first R&D milestone using its proprietary Pharma.AI platform, triggering an undisclosed milestone ...
Operating profit reaches KRW 640 billion as Plant 5 ramp-up and US operations strengthen performance, prompting the CDMO ...
Metabolon, Inc., the global leader in metabolomics solutions advancing life sciences research, diagnostics, therapeutics, and precision medicine, announced Splash & Ripple, a new bioinformatics ...
The new fiscal year is already two days into its own ledger. On 2 October 2026, FDA issued a letter to Hanlim Pharm in Yongin ...
Oracle announced an agreement with AstraZeneca to explore how AI and real-world data can help clinicians identify eligible ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results